Steven Feldon, MD, the director of University of Rochester Medical Center Flaum Eye Institute, has been named president of the Association of University Professors of Ophthalmology.
Ophthalmology
Eye Excellence's Mary Green, MD, a board-certified ophthalmologist, has been received the 2012 Sightpath Top Surgeon award.
Bausch + Lomb's experimental glaucoma medication, BOL 303259-X, has shown a greater reduction of intraocular pressure than the current standard glaucoma treatment, latanoprost, according to a Medscape report.
The New York Ear and Eye Infirmary recently published a study showing Diopsys NOVA-LX Visual Evoked Potential Vision Testing System to be an effective tool in the early detection of glaucoma.
Calvin Christopher Brown, MD, a retinal fellow at the Eye Specialty Group in Memphis, Tenn., will be offering his services at all four San Antonio Eye Center locations.
Advertisement
Bausch + Lomb, leading ophthalmology company, is planning for an initial public offering of stock and intends to use the proceeds to repay a $700 million loan, according to an Optics report.
Balamurali Ambati, MD, of the University of Utah in Salt Lake City, is leading a team of researchers in the study of polymer nanoparticles as a treatment for macular degeneration, according to a report by Chemical & Engineering News.
Insite Vision, an Alameda, Calif.-based ophthalmic products company, has recruited Gholam A. Peyman, MD, to its Scientific Advisory Board.
Daniel Durrie, MD, a board-certified ophthalmologist, has co-created and introduced SBK LASIK at his Durrie Vision practice in Overland Park, Kan.
San Francisco 9th U.S. Circuit Court of Appeals ruled that federal law prevents patients that had LASIK surgery from suing surgeons and doctors for not explaining that LASIK was not approved as a farsightedness treatment, according to a Thomson Reuters…